Verrica Pharmaceuticals Inc. (VRCA) rose 16.58 percent to $4.71 on Friday, gaining $0.67, after its partner Torii Pharmaceutical received Japanese Ministry of Health, Labour and Welfare approval for YCANTH to treat Molluscum Contagiosum. The stock opened at $4.48 and traded between $4.35 and $4.90, compared with a previous close of $4.04 on the Nasdaq. Trading volume reached 7.34 million shares, far above the average of 0.06 million. Verrica trades within a 52-week range of $3.82 to $19.50.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.